Lab Information
Peter Lakatos (MD)
InvestigatorClinical Research Unit
Department of Medicine (McGill)
Research Profile
Keywords
Inflammatory bowel diseases (IBD) • gastroenterology • colitis • Crohn’s diseaseTeam Members
| Name | Position |
|---|
Latest Publications
- Wewer, M. D., Lophaven, S., Lakatos, P. L., Gonczi, L., Salupere, R., Linda Kievit, H. A., Nielsen, K. R., Midjord, J., Domislovic, V., Krznarić, Ž., Pedersen, N., Kjeldsen, J., Halfvarson, J., Sebastian, S., Goldis, A., Arebi, N., Oksanen, P., Neumann, A., Andersen, V., Katsanos, K. H., Koukoudis, A., Turcan, S., Ellul, P., Kupcinskas, J., Kiudelis, G., Fumery, M., Kaimakliotis, I. P., D'Inca, R., Lombardini, S., Hernandez, V., Fernandez, A., Langholz, E., Munkholm, P., Burisch, J. & Epi-IBD-group. (2025). Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
- Angyal, M. M., Pangestu, S., Lakatos, P. L., Brodszky, V. & Rencz, F. (2025). Psychometric testing of the ICECAP-A in patients with coeliac disease: a comparative analysis with EQ-5D-5L. Health and quality of life outcomes, vol. 23, p. 112.
- Ongay, J., Candel, I., Bitton, A., Afif, W., Bessissow, T. & Lakatos, P. L. (2025). Case Report: Secukinumab (Interleukin-17 Inhibitor) and Ulcerative Colitis Flare - the Double-Edged Sword. Case reports in gastroenterology, vol. 19, p. 637-643.
- Drügg Hahn, G., Lakatos, P. L., Maedler-Kron, C., Marcus, V., Afif, W., Wild, G., Bitton, A., Flores, C., de Magalhães Francesconi, C. F. & Bessissow, T. (2025). Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis. Inflammatory bowel diseases.
- Allocca, M., Jairath, V., Sands, B. E., Rubin, D. T., Caron, B., Laurent, V., Novak, K., Panaccione, R., Bossuyt, P., Bruining, D. H., Dignass, A., Dotan, I., Fletcher, J., Fumery, M., Furfaro, F., Halfvarson, J., Hart, A., Kobayashi, T., Krugliak Cleveland, N., Kucharzik, T., Laghi, A., Lakatos, P. L., Leong, R. W., Loftus, E. V., Louis, E., Magro, F., Olivera, P. A., Sebastian, S., Siegmund, B., Vavricka, S. R., Wilson, S. R., Stoker, J., Rimola, J., Peyrin-Biroulet, L. & Danese, S. (2025). International consensus on the use of intestinal ultrasound in inflammatory bowel disease trials. Journal of Crohn's & colitis, vol. 19.
- Shehab, M., Alrashed, O., Alrashed, F., Alyousefi, R., Zoughlami, A., Lakatos, P., Allez, M., Jairath, V., Regueiro, M. & Bessissow, T. (2025). Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-Analysis. Inflammatory bowel diseases.
- Kritzinger, J., Kotrri, G., Lakatos, P. L., Bessissow, T. & Wild, G. (2025). The Role of Biomarkers in Surveillance of Ulcerative Colitis-Associated Colorectal Cancer: A Scoping Review. Journal of clinical medicine, vol. 14.
- Farkas, B., Resál, T., Lakatos, P. L., Bessissow, T., Limdi, J. K., Armuzzi, A., Bezzio, C., Savarino, E. V., Saibeni, S., Michalopoulos, G., Attauabi, M., Seidelin, J. B., Fousekis, F. S., Katsanos, K., Bacsur, P., Bálint, A., Ivány, E., Szepes, Z., Farkas, K. & Molnár, T. (2025). Upadacitinib is associated with better clinical and biochemical outcomes than tofacitinib in refractory, moderate-to-severe UC. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
- Balogh, F., Gonczi, L., Angyal, D., Golovics, P. A., Pandur, T., David, G., Erdelyi, Z., Szita, I., Ilias, A., Lakatos, L. & Lakatos, P. L. (2025). Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort. World journal of gastroenterology, vol. 31, p. 109800.
- Balogh, F., Angyal, D., Varga, A., Gonczi, L., Lontai, L., Ilias, A. & Lakatos, P. L. (2025). Efficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management. Expert opinion on biological therapy, p. 1-12.
See also
